• Title/Summary/Keyword: Integrative Korean medicine treatment

Search Result 464, Processing Time 0.027 seconds

The Study on the Safety and Case Series of the Acute Lymphocytic Leukemia using Rhus Verniciflua Stokes Extract (Nexia) (건칠(乾漆) 추출물(Nexia)의 독성 실험과 급성 림프 구성 백혈병환자의 임상증례군 보고)

  • Park, Jae-Woo;Kim, Kyung-Suk;Jung, Hyun-Sik;Choi, Won-Cheol;Yoon, Seong-Woo
    • Journal of Korean Traditional Oncology
    • /
    • v.11 no.1
    • /
    • pp.1-21
    • /
    • 2006
  • This study was undertaken to evaluate safety and antitumor activity of Nexia, a processed extract of Rhus verniciflua STOKES by heating according to Korean patent 0504160 through toxicology, cancer research and clinical application. Nexia did not exhibit any toxicological symptoms through 13 week continuous treatment, dosage accumulation study and anaphylaxis response. The lifespan of four patients with acute lymphocytic leukemia under complete remission were 110, 83, 97, and 86 months after treatment of Nexia, respectively. These data suggest that Nexia, a processed extract by removing allergen from Rhus verniciflua STOKES, may have safety and antitumor activity and also still need continuous study on its mechanism and clinical trial.

  • PDF

Facial Nerve Damage in Bell's Palsy according to When Korean Medical Treatment was Started : A Retrospective Study (벨마비 환자의 한의학적 치료 시작시기에 따른 신경손상률 비교 : 후향적 관찰 연구)

  • Choi, Ji Eun;Kwon, Min Soo;Kim, Jung Hwan;Jo, Dae Hyun;Han, Ji Sun;Jo, Hee Jin;Kim, Ji Hye;Kim, Hyun Ho;Kang, Jung Won;Nam, Dong Woo
    • Journal of Acupuncture Research
    • /
    • v.33 no.2
    • /
    • pp.51-60
    • /
    • 2016
  • Objectives : Although integrative Korean medical treatments have been suggested to be effective for treating Bell's palsy, the effect of Korean medical treatment according to when treatment was started is unknown in the clinical field. Therefore, this study was conducted to determine the results of treating Bell's palsy according to different starting points of integrative Korean medical treatments. Methods : We screened patients who visited the Facial Palsy Center at Kyung Hee University Hospital for Korean and Western combined medical treatment from March 2011 to February 2016. A total of 821 out of 2086 patients were studied, including their basic characteristics and results of an electromyography. Patients who started Korean medical treatment within 3 days of onset were placed in group A, within 9 days of onset in group B, and patients who started treatment after 10 days of onset were placed in group C. We tried to compare the level of facial nerve damage by electromyography between groups. Results : The patients in group C had the highest axonal loss rates in all branches(frontal, oculi, nasal, oris). The post hoc analyses revealed the difference of axonal loss rates between group A and B was not statistically significant. Only group C showed statistically higher axonal loss rates in all branches. Conclusion : The study results showed that the patients who had delayed Korean medical treatments had a higher level of facial nerve damage by electromyography. According to the results of this study, early application of integrative Korean medical treatment is suggested.

Study of comprehensive and integrative treatment using acupuncture for cancer pain through publication review (논문 리뷰를 통한 암성통증에 대한 침을 이용한 양한방 통합치료 효과 연구)

  • Kwak, Sang Gyu;Sohn, Ki Cheul;Shin, Im Hee;Kim, Sang Gyung;Jung, Hyun-Jung;Lee, A-Jin;Cho, Yoon-Jeong;Kim, Dal Ho
    • Journal of the Korean Data and Information Science Society
    • /
    • v.26 no.6
    • /
    • pp.1327-1334
    • /
    • 2015
  • Cancer pain is a very important factor in cancer patients refractory to drop the quality of life of cancer patients. The worldwide trend is an integrated effort by both the western medicine and korean traditional medicine of treatment increases to reduce cancer pain. There are many studies related to cancer pain through an integrated medicine approach. Many study was reported that acupuncture treatment is effective for fatigue, xerostomia, insomnia, anxiety and quality of life. However, despite the practical clinical effects and various case reports of acupuncture, many still disagree about the significance of an integrated treatment of pain reduction with acupuncture. Therefore, we has identified that reduce effect of comprehensive and integrative treatment using acupuncture for cancer pain through publication review. And we evaluated effect of comprehensive and integrative treatment using acupuncture through summary of values in each publication.

Effects of Acupuncture on Urinary Incontinence in Premenopausal Women : Preliminary Study (폐경 전 여성 요실금에 대한 침치료 효과 : 예비연구)

  • Yun, Young-Ju;Kang, Kyung-Won;Yang, Ju-No;Chun, Mi-Son;Choi, Jong-Bo;Yang, Jeong-In
    • Journal of Acupuncture Research
    • /
    • v.28 no.3
    • /
    • pp.55-71
    • /
    • 2011
  • Objectives : The purposes of this preliminary study was to examine the feasibility of recruiting women into a clinical trial designed to examine the effects of acupuncture in treating urinary incontinence (UI) in premenopausal women with delivery history and the feasibility of performing the study procedures. We also tried to determine if there was preliminary evidence to suggest that acupuncture may be effective in reducing UI and improving disease-specific quality of life. Methods : This study was a pragmatic randomized clinical trial. Subjects between the ages of 20 and 49 years were randomly assigned to a treatment(n=11) or control group(n=11) and analyzed. Both groups were supposed to do Kegel exercise at home during 4 weeks and acupuncture was applied to the treatment group twice a week(8 sessions) additionally. Subjects performed 1 hour pad test and completed a 3-day urination diary, international consultation on incontinence modular questionnaire(ICIQ), and incontinence - quality of life(I-QOL) at base line and 5 weeks. Results : Both group showed improvement in 1 hour pad test and the reducing amount of UI was significantly larger in treatment group(p=0.0182). The significant improvements in ICIQ and I-QOL were also observed in treatment group and sustained until the follow-up measurement at 16 weeks. Any adverse reaction related to acupuncture did not happen. Conclusions : It was feasible to recruit subjects and perform the study procedures. The positive results of this study support the requirement for additional research investigating the efficacy of acupuncture in the treatment of UI in women.

The Role of Korean Medicine for Treatment and Management for Lung Cancer (폐암 환자의 치료 및 관리에서 한의학적 치료의 역할)

  • Jung, Hyun-Jung;Kim, Jong-Dae
    • Journal of Korean Traditional Oncology
    • /
    • v.20 no.1
    • /
    • pp.45-54
    • /
    • 2015
  • Objectives : Lung cancer is the leading cause of death in cancer patients. Many studies reflect the growing application of integrative korean and western medicine for lung cancer, but its efficacy remains largely unexplored. The purpose of this study is to show that the role of Korean medicine for treatment and manage for lung cancer patients. Methods : In the present study, we searched all the clinical studies of Korean Medical therapies for lung cancer by electronic and manual searching in two databases including MEDLINE, OASIS. Results : Our study showed that acupuncture has strong immunomodulatory effect. Further analysis revealed that acupuncture and herb medicine alleviate the conventional therapy-induced bone marrow supression in lung cancer patients, as well as desease nausea and vomiting. In this study, we showed that acupuncture and herb medicine can improve immediate tumor response, quality of life of lung cancer patients. Conclusions : Korean medicine including that acupuncture and herb medicine is found to be effective in lung cancer treatment and management.

Development and Validity Test on Preliminary Critical Pathway of Integrative Medicine for Lung Cancer Patients Treated with Chemotherapy ('항암화학요법을 받은 폐암 환자의 예비 통합의학 임상경로' 개발 및 타당도 평가)

  • Hong, Minna;Shim, So-hyun;Yoon, Seong-hoon;Choi, Jun-yong;Kim, Yun-seong
    • The Journal of Internal Korean Medicine
    • /
    • v.38 no.6
    • /
    • pp.917-929
    • /
    • 2017
  • Objectives: The objective of this study was to investigate the validity of the preliminary critical pathway of integrative medicine to improve the quality of life of lung cancer patients who received chemotherapy. Methods: The vertical axis of the preliminary critical pathway of integrated medicine consisted of nine domains: assessment, treatment, activity, consult, diet, medication, Korean medical examination, education, and others. The frame of the horizontal axis was the date from hospitalization to discharge. A total of 105 items in this preliminary critical pathway were validated by an expert group from October 28, 2016 to November 4, 2016. A total of ten experts from two different medical institutions participated in the validity test, using the four-point Content Validity Index (CVI) scale. The items with validity of greater than 80% were considered as significant. Results: The analysis of the content validity of 105 items showed 102 items with greater than 80% agreement. Assessment, treatment, consult, diet, medication, and education showed 100% agreement. Only three items showed a low validity (62.5%). Based on additional comments, the preliminary critical pathway of integrative medicine has been supplemented. Conclusions: This study suggests the possibility of using the integrated medical critical pathway for patients with lung cancer who received chemotherapy.

Role of Glyco-Persica® in Targeting Diabetes Type 2: an Integrative Approach

  • Dashtdar, Mehrab;Dashtdar, Mohammad Reza;Dashtdar, Babak;Khan, Saeed Ahmad
    • Journal of Pharmacopuncture
    • /
    • v.16 no.4
    • /
    • pp.14-21
    • /
    • 2013
  • Objectives: The objective of this study was to examine how an integrated approach to type 2 diabetes mellitus treatment could improve glycemic control and immune-potentiating activities adherent to oral hypoglycemic agents along with a botanical compound, among primary care patients. Methods: In this study, we used the self-control and the group-control methods. Candidates meeting the trial conditions were selected from among volunteers who had taken the test substance for 45 days. During the trial, all groups were on a controlled diet; neither were the original medications nor their dosages changed. Results: The results showed that the botanical compound (Glyco-Persica$^{(R)}$) significantly reduced the main clinical symptoms in diabetes type 2. In the treatment group, 36 of 52 patients (69.23%) and in the control group 10 of 52 patients (19.23%) showed reduced symptoms, and this difference was statistically significant (P < 0.05). The fasting blood sugar in the treatment group after treatment compared with that before treatment and with that in the control group after treatment was statistically different (P < 0.05). The post-prandial glucose in the treatment group after treatment was significantly different from that before treatment and from that in the control group after treatment (P < 0.05); the post-prandial blood sugar in the treatment group was reduced by 8.98%. Conclusions: The results revealed that the botanical compound (Glyco-Persica$^{(R)}$) has significant hypoglycemic properties which affect main clinical symptoms in diabetes type 2. Body weight, blood pressure, heart rate, routine blood, stool and urine tests showed no meaningful negative changes after the course of treatment. There was no significant adverse reaction during the trial.

A Case Report of Metastatic Breast Cancer Patient Treated with Integrative Cancer Treatment (전이성 유방암 환자의 통합 암 치료에 대한 증례보고)

  • Ha, Su-jeong;Lee, Sung-cheol;Park, So-jung;Jeon, Hyung-joon;Lee, Yeon-Weol;Cho, Chong-kwan;Yoo, Hwa-seung
    • Journal of Korean Traditional Oncology
    • /
    • v.24 no.1
    • /
    • pp.19-28
    • /
    • 2019
  • Objective : The purpose of this study is to report and observe effects of Integrative Cancer Treatment (ICT) on metastatic breast cancer patient. Method : A left breast cancer patient diagnosed with recurrence on liver and bones April 2018. The patient had received paclitaxel chemotherapy for two months and discontinued it because of tumor progression and side effects. The patient has been treated with ICT since March 2018 and has been taking capecitabine since October 2018. The clinical outcomes were measured by computed tomography, laboratory findings including tumor markers (CEA, CA15-3). The clinical outcomes were measured by computed tomography, laboratory findings including tumor markers (CEA, CA15-3), liver function test (AST, ALT), Eastern Cooperative Oncology Group performance status (ECOG PS), and numeric rating scales (NRS). Results : After the ICT, tumor size was partially decreased accompanying by reducing the levels of tumor markers. Major clinical symptoms induced by paclitaxel chemotherapy were improved. There were no severe adverse events induced by ICT based on National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) version 5.0. Conclusion : This case suggests that ICT may have synergistic effect for the treatment of metastatic breast cancer patient in conjunction with capecitabine.

Current Research Trends in Randomized Controlled Trials Investigating the Combined Effect of Korean Medicine and Western Medicine Treatment

  • Ha, Dohyung;Kim, Seoyeon;Baek, Yong Hyeon;Won, Jiyoon;Nam, Seri;Shin, Jeeyoung;Kwon, Oh-Hoon;Kim, Soo-Yeon;Lee, Hyangsook
    • Journal of Acupuncture Research
    • /
    • v.37 no.1
    • /
    • pp.13-18
    • /
    • 2020
  • This review examined recently published (July 2014 to June 2017), randomized controlled trials (RCTs) which investigated the safety and effectiveness of combined Korean medicine/complementary alternative medicine (CAM) and Western medicine, to indicate the direction for integrative medical practice. The Korean Medicine Convergence Research Information Center evidence-based medicine database (KMCRIC EBM DB) was used to retrieve relevant RCTs indexed in the last 3 years. Study design, country, sample size, disease/condition with the Korean Standard Classification of Diseases code, interventions, direction of outcomes, and adverse events were extracted and summarized. A total of 93 RCTs were included in this review. Acupuncture/moxibustion was the most commonly used intervention (n = 47; 51%), and 19% (n = 18) of the studies treated musculoskeletal disorders, followed by circulatory disorders (n = 16; 17%), and mental and behavioral disorders (n = 9; 10%). Integrative treatment was reported as more effective than monotherapy in approximately 83% of these studies. Adverse events were poorly reported in most studies. This review suggests that integrative treatments are feasible, effective, and safe for various diseases/conditions, based on the evidence from recently published RCTs. Future studies on integrative healthcare are warranted.

A case of breast cancer Patient Treated with Allergen Removed Rhus Verniciflua Stokes(ARV) (알러젠 제거(除去) 옻나무 추출물(抽出物) 투여(投與)로 호전(好轉)된 유방암(乳房癌) 환자 1례)

  • Kim, Cho-Young;Park, Jae-Woo;Jung, Hyun-Sik;Choi, Won-Cheol;Yoon, Seong-Woo
    • Journal of Korean Traditional Oncology
    • /
    • v.12 no.1
    • /
    • pp.67-73
    • /
    • 2007
  • Breast cancer is common in West and Incidence of breast cancer has increased in Korea. According as conventional western medical treatment, breast cancer patient received MRM(modified radical mastectomy) and anti cancer chemotherapy. In this case report, We introduce a case of breast cancer patient who showed lung metastasis(metastatec adenocarcinoma) after MRM(modified radical mastectomy) 4 years before the diagnosis of relapse. After lung metastasis of breast cancer, the patient received 4th chemotherapy and refused to get more conventional western medical treatment including chemotherapy. After 24 month of traditional oriental medical treatment using allegen removed Rhus Verniciflua Stokes(ARV), however, the size of cancer mass decreased and the patient showed improved condition. Further case study will be needed in order to determine the effect of ARV on breast cancer patient.

  • PDF